HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M800335-MCP200v1 8/4/799    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lal, S. Articles by dos Remedios, C. Search for Related Content PubMed PubMed Citation Articles by Lal, S. Articles by dos Remedios, C. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 8:799-804, 2009.
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Using Antibody Arrays to Detect Microparticles from Acute Coronary Syndrome Patients Based on Cluster of Differentiation (CD) Antigen Expression^*

Sean Lal^,, Angus Brown, Lisa Nguyen^¶, Filip Braet^||, Wayne Dyer^** and Cris dos Remedios

From the School of Medical Sciences, Bosch Institute, ^¶ School of Molecular and Microbial Sciences, and ^|| Electron Microscopy Unit, The University of Sydney, Sydney 2006, Australia and ^** Immunovirology Laboratory, Australian Red Cross Blood Service, Sydney 2000, Australia

Microparticles circulate in plasma and have recently emerged as potential inflammatory markers in cardiovascular disease. They are fragments of cell membranes that express cluster of differentiation (CD) antigens and are present at elevated levels in patients with acute coronary syndrome. We have developed a novel method for the rapid detection of microparticles in plasma using a fluorescence-based antibody array system. Isolated microparticles are captured on anti-CD antibody spots immobilized on a nitrocellulose membrane. These CD antibodies are directed against extracellular epitopes, whereas the intracellular exposed surface of the microparticles is labeled with a fluorescent anti-annexin antibody. The array is then scanned and quantified. A pilot study was undertaken to compare microparticle CD antigen expression in acute coronary syndrome and healthy subjects. Ten CD antigens (44, 45, 54, 62E, 79, 102, 117, 130, 138, and 154) had significantly increased expression in the disease group relative to the healthy controls. These results were then verified using flow cytometry and scanning electron microscopy. Although we have focused our analysis on changes in microparticle CD antigen expression, this technique is amenable to analyzing other surface markers. Microparticles can be derived from a wide variety of cell types, so selection of the primary antibody can be tailored to the cell origin that is to be investigated.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?